Tenon Medical, Inc. (TNON): Nasdaq/NYSE listing notice — Tenon Medical receives Nasdaq non-compliance notice over independent director shortfall after resignation

Tenon Medical, Inc.

Frank Fischer resigned from Board and all committees effective Nov 30, 2023, causing non-compliance.
Board now has 6 directors, only 3 independent; Audit Committee has 2 of 3 needed, Compensation Committee 1 of 2.
Cure period runs until earlier of next annual meeting or Nov 30, 2024; if annual meeting before May 28, 2024, compliance due May 28, 2024.
Company intends to appoint one or more independent directors to fill vacancies during cure period.
Notice has no immediate effect on listing or trading of common stock or warrants on Nasdaq.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Tenon Medical, Inc. received a nasdaq deficiency notice notice regarding audit committee (rules 5605, 5605(b)(1)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: audit committee
Rules: 5605, 5605(b)(1)(A)

Exact text from the filing

January 4, 2024, Tenon Medical, Inc. (the “Company”) received a written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) dated January 4, 2024, indicating that, as a result of Frank Fischer’s resignation from the Board of Directors of the Company (“Board”), audit committee of the Board (the “Audit Committee”) and compensation committee of the Board (the “Compensation Committee”), effective November 30, 2023, that the Company is not currently in compliance with Nasdaq Listing Rule 5605, which requires that (i) a majority of the Board be comprised of independent directors, (ii)

View on SEC.gov

Browse all listing & compliance notices →

Tenon Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-003047

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.